Renhong Sun

681 total citations
19 papers, 502 citations indexed

About

Renhong Sun is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Renhong Sun has authored 19 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Renhong Sun's work include Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (7 papers) and Peptidase Inhibition and Analysis (5 papers). Renhong Sun is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (7 papers) and Peptidase Inhibition and Analysis (5 papers). Renhong Sun collaborates with scholars based in China, United States and South Korea. Renhong Sun's co-authors include Xiaobao Yang, Biao Jiang, Chaowei Ren, Yuanhong Liu, Haoyi Chen, Hongli Chen, Ning Sun, Qianqian Yin, Xin Xie and Jinju Chen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Renhong Sun

19 papers receiving 494 citations

Peers

Renhong Sun
Mette Ishoey Denmark
Maryanna E. Lanning United States
Honorine Lebraud United Kingdom
Stephen J. Atkinson United Kingdom
Niall A. Anderson United Kingdom
Suhong Pang United States
Matthew Lindon United Kingdom
Ellen M. Leahy United States
Alison E. McGonagle United Kingdom
Mette Ishoey Denmark
Renhong Sun
Citations per year, relative to Renhong Sun Renhong Sun (= 1×) peers Mette Ishoey

Countries citing papers authored by Renhong Sun

Since Specialization
Citations

This map shows the geographic impact of Renhong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renhong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renhong Sun more than expected).

Fields of papers citing papers by Renhong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renhong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renhong Sun. The network helps show where Renhong Sun may publish in the future.

Co-authorship network of co-authors of Renhong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Renhong Sun. A scholar is included among the top collaborators of Renhong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renhong Sun. Renhong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sun, Renhong, Zhongli Xu, Huen Suk Kim, et al.. (2025). Discovery of the first-in-class DOT1L PROTAC degrader. European Journal of Medicinal Chemistry. 291. 117595–117595. 2 indexed citations
2.
Gumpper, Ryan H., Manish K. Jain, Kuglae Kim, et al.. (2025). The structural diversity of psychedelic drug actions revealed. Nature Communications. 16(1). 2734–2734. 10 indexed citations
3.
Wu, Wenyong, Renhong Sun, Dingyan Wang, et al.. (2024). Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR–ABL–Positive Leukemia. Cancer Research. 85(1). 101–117. 4 indexed citations
4.
Zhu, Xiaotong, Haixia Liu, Yuetong Wang, et al.. (2024). NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers. Cell chemical biology. 31(6). 1203–1218.e17. 6 indexed citations
5.
Chen, Li, Yunfeng Zou, Renhong Sun, et al.. (2024). Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader. Cell Death and Disease. 15(12). 898–898. 2 indexed citations
6.
Sun, Renhong, et al.. (2023). Research and Application of Prefabricated Steel Structure Inner Partition Connection Technology. Academic Journal of Science and Technology. 7(2). 24–27. 1 indexed citations
7.
Zhang, Yanchun, Renhong Sun, Xiaotong Zhu, et al.. (2023). Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness. Journal of Biological Chemistry. 299(6). 104825–104825. 9 indexed citations
8.
Li, Fenglei, Qiaoyu Hu, Renhong Sun, et al.. (2022). DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs. Nature Communications. 13(1). 7133–7133. 88 indexed citations
9.
Sun, Renhong, Haixia Liu, Chaowei Ren, et al.. (2022). Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators. European Journal of Medicinal Chemistry. 247. 115016–115016. 3 indexed citations
10.
11.
Liu, Haixia, Chaowei Ren, Renhong Sun, et al.. (2022). Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation. Chemical Communications. 58(72). 10072–10075. 50 indexed citations
12.
Ren, Chaowei, Ning Sun, Haixia Liu, et al.. (2021). Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile. Journal of Medicinal Chemistry. 64(13). 9152–9165. 32 indexed citations
13.
Liu, Haixia, Renhong Sun, Chaowei Ren, et al.. (2020). Construction of an IMiD-based azide library as a kit for PROTAC research. Organic & Biomolecular Chemistry. 19(1). 166–170. 24 indexed citations
14.
Zhao, Quanju, Chaowei Ren, Linyi Liu, et al.. (2019). Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase. Journal of Medicinal Chemistry. 62(20). 9281–9298. 104 indexed citations
15.
Xie, Xin, et al.. (2016). Nickel‐Catalyzed [2+2+2] Cycloaddition of Alkyne‐Nitriles with Alkynes Assisted by Lewis Acids: Efficient Synthesis of Fused Pyridines. Chemistry - A European Journal. 22(47). 16765–16769. 38 indexed citations
16.
Sun, Renhong, Jun Liu, Shuang Yang, et al.. (2015). Cp2TiCl2-catalyzed cis-hydroalumination of propargylic amines with Red-Al: stereoselective synthesis of Z-configured allylic amines. Chemical Communications. 51(29). 6426–6429. 23 indexed citations
17.
Yu, Shasha, Renhong Sun, Haoyi Chen, Xin Xie, & Yuanhong Liu. (2014). Zirconium‐Mediated Multicomponent Reactions of 1,3‐Butadiynes with Ylidenemalononitriles to Form Functionalized 1,8‐Naphthyridine and Cyclopenta[b]pyridine Derivatives. Chemistry - A European Journal. 21(4). 1420–1424. 4 indexed citations
19.
Zhao, Jingjing, Pan Li, Chunrui Wu, et al.. (2011). Aryne [3 + 2] cycloaddition with N-sulfonylpyridinium imides and in situ generated N-sulfonylisoquinolinium imides: a potential route to pyrido[1,2-b]indazoles and indazolo[3,2-a]isoquinolines. Organic & Biomolecular Chemistry. 10(9). 1922–1922. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026